Literature DB >> 2473600

Substance P and vasoactive intestinal peptide influence polyamine metabolism in salivary glands of the rat.

J Ekström1, B O Nilsson, E Rosengren.   

Abstract

In parotid, sublingual and submaxillary glands stimulated by continuous intravenous infusion of the neuropeptides substance P or vasoactive intestinal peptide at various doses for 3 h, the concentrations of the polyamines putrescine, spermidine, spermine and N1-acetylspermidine as well as the activity of ornithine decarboxylase were determined. This enzyme catalyses the synthesis of putrescine and is the key enzyme in polyamine formation. Vasoactive intestinal peptide induced the most marked effects, and the most conspicuous findings were made in the sublingual glands, where the ornithine decarboxylase activity was found to have increased more than 100-fold, accompanied by an increased level of putrescine in those glands which were removed immediately after the end of the infusion. When, instead, the glands were removed 5 h after the end of the infusion there was no longer any increase in the activity of ornithine decarboxylase or in putrescine concentration, but now spermidine and spermine were found to be increased. Interestingly, the parasympathetic non-adrenergic, non-cholinergic regulation of polyamine metabolism in the major salivary glands of the rat is most predominant in the sublingual glands.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473600     DOI: 10.1111/j.1748-1716.1989.tb08684.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  2 in total

1.  The distribution and origin of nerve fibers immunoreactive for substance P and neurokinin A in the anterior buccal gland of the rat.

Authors:  J Törnwall; H Uusitalo; Y T Konttinen
Journal:  Cell Tissue Res       Date:  1994-08       Impact factor: 5.249

2.  Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats.

Authors:  B Månsson; B O Nilsson; J Ekström
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.